India and South Korea approve Gilead’s remdesivir for emergency use against COVID-19
June 3, 2020Research and Development, Sales and Marketing COVID-19, Gilead, India, coronavirus, remdesivir, south korea
India and South Korea have moved to follow in the footsteps of the US in approving Gilead’s antiviral therapy remdesivir …
Lancet expresses concern over published hydroxychloroquine and chloroquine paper
June 3, 2020Research and Development COVID-19, chloroquine, coronavirus, hydroxychloroquine
The Lancet’s editors have expressed their concerns over a paper published in their journal that said hydroxychloroquine and chloroquine was …
The Association of American Physicians & Surgeons sue FDA to end restrictions on hydroxychloroquine, despite evidence it can be life threatening
June 3, 2020Research and Development AAPS, COVID-19, coronaviryus
The Association of American Physicians & Surgeons have filed a lawsuit against the FDA due to it blocking widespread access …
Kings College London launches trial investigating the effectiveness of ibuprofen in COVID-19 patients
June 3, 2020Research and Development COVID-19, coronavirus, ibuprofen
Kings College London has launched a clinical trial to investigate how effective a formulation of ibuoprofen is in reducing respiratory …
Pharmafile.com’s weekly COVID-19 news round-up
June 3, 2020Research and Development COVID-19, coronavirus
COVID-19 treatments dominate the news this week as Russia is set to start its roll out of the anti-viral drug …
Eli Lilly launches clinical trial of COVID-19 antibody treatment
June 2, 2020Manufacturing and Production COVID-19, coronavirus
Eli Lilly has announced they have started an early stage human trial to test an antibody treatment against coronavirus. The …
Sanofi’s Sarclisa combo approved in Europe for relapsed/refractory multiple myeloma
June 2, 2020Manufacturing and Production, Sales and Marketing Europe, Sanofi, Sarclisa, pharma
Sanofi has scored a new approval from the European Commission for the use of its CD38 inhibitor Sarclisa (isatuximab) in …
AI firm that worked with Vote Leave awarded contract to help Britain deal with COVID-19
June 2, 2020Manufacturing and Production
The AI company Faculty, who worked on the Vote Leave campaign, have been awarded a £400,000 contract by the government …
Antidepressant Zoloft falls into shortage due to anxiety around COVID-19
June 2, 2020Manufacturing and Production COVID-19, coronavirus
The FDA has listed the antidepressant Zoloft to its catalogue of drugs that are in short supply in the United …
Five-day remdesivir regimen shows promising clinical benefit in COVID-19 patients, Phase 3 data shows
June 2, 2020Manufacturing and Production, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir
Gilead has unveiled eagerly anticipated new Phase 3 data on the addition of its antiviral therapy remdesivir to standard of …
Ipsen appoints David Loew as new Chief Executive Officer
June 1, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
David Loew will leave his position as the head of Sanofi’s vaccine division to become the Chief Executive Officer of …
How Big Brother is helping to fight COVID-19
June 1, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, NHS, coronavirus, feeature, pharma, track and trace
Following the unprecedented disruption created by COVID-19, many governments are increasingly looking at using data from contact-tracing apps to help …
Russia to begin administering anti-viral COVID-19 drug next week
June 1, 2020Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Russia, coronavirus, pandemic, virus
Russia will start its roll out of the anti-viral drug Avifavir (favipiravir) to COVID-19 patients next week, according to the …
Gilead’s magrolimab shows promising responses in untreated myelodysplastic syndrome and acute myeloid leukaemia at ASCO 2020
June 1, 2020Research and Development, Sales and Marketing ASCO 2020, Cancer, Gilead, leukaemia, magrolimab
Gilead took the opportunity at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting to unveil new Phase 1b …
Significant lack of women and minorities involved in clinical trials for cardiometabolic medication, research shows
June 1, 2020Sales and Marketing cardio, cardiovascular, cvd
Women and minorities, particularly African Americans, continue to be under represented in clinical trials for cardiometabolic medication, according to a …
Lynparza secures CHMP recommendation in first-line BRCA-mutated metastatic pancreatic cancer
June 1, 2020Sales and Marketing AstraZeneca, Cancer, MSD, Pancreatic cancer, lynparza
Lynparza (olaparib), the PARP inhibitor developed by AstraZeneca and MSD, has just secured recommendation for approval from the European Medicines …
US donates $1 billion to Oxford University’s COVID-19 vaccine in exchange for 300 million doses
June 1, 2020Sales and Marketing COVID-19, coronavirus
The US has given $1 billion to AstraZeneca to advance the development and production of the vaccine they are creating …
First ever benefit-risk analysis is “favourable” for remdesivir as COVID-19 treatment
May 29, 2020Medical Communications, Research and Development COVID-19, DSRU, Gilead, coronavirus, pharma, remdesivir
The UK-based Drug Safety Research Unit (DSRU) has reported its findings from the first ever systematic benefit-risk analysis of Gilead’s …
Leukaemia drug nilotinib shows promise against Alzheimer’s in small clinical study
May 29, 2020Medical Communications Alzheimer's, leukaemia
The leukemia drug nilotinib has shown promise in reducing the effects of Alzheimer’s disease and while having safe and minimal …
Top Ten most popular articles on Pharmafile.com this week
May 29, 2020Medical Communications COVID-19, coronavirus, top 10
GlaxoSmithKline features prominently in the news this week, as they pledged to pay a cash bonus of £1,500 to staff …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
